USANA posts record Q2 sales of $336.8M (+30.1% YoY); EPS $1.87 (+41.7% YoY)

USANA HEALTH SCIENCES INC

2022-Q2 EPS reported $3.31 revenue$644,813,000

Q2 net sales $336.8M, +30.1% YoY; diluted EPS $1.87, +41.7% YoY; active customers 652K (+8.8%).
Asia Pacific sales $279M (+33.3% YoY); Americas & Europe $57.9M (+16.5% YoY).
Gross margin improved 150bps to 83.1%; associate incentives rose 290bps to 45.7% of sales.
Repurchased 304K shares for $29.7M in Q2; $51M remaining under authorization.
FY2021 outlook reiterated: net sales $1.24-$1.28B, diluted EPS $6.15-$6.50.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.